Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This is a phase II, randomised, double-blind, placebo-controlled, multiple-dose, multi-center study of AbGn-168H in subjects with moderate to severe chronic plaque psoriasis. The objectives of this study is to investigate efficacy, safety, tolerability, and pharmacokinetics (PK) of multiple doses of AbGn-168H administered intravenously to patients with moderate to severe chronic plaque psoriasis.
Critère d'inclusion
- Moderate To Severe Chronic Plaque Psoriasis